A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver Function
Completed · Phase 1
Conditions studied: Hepatic Impairment, Healthy Volunteers
In brief
The main aim is to check the effect of a single dose of soticlestat in adults with moderate or mild liver failure compared to healthy adults with normal liver function. Participants will check into the study clinic for 8 days. During the stay, one oral dose of soticlestat will be given and the participant will be monitored. The clinic staff will follow up with the participant about a week after discharge from the clinic.
Key facts
- Study ID
- NCT05098054
- Run by
- Takeda
- People needed
- 36
- Starts
- 2021-10-29
- Expected to finish
- 2022-06-07
- Last updated by the study team
- 2024-02-02
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
Where it is running
- Velocity — Edgewater, Florida, United States
- Clinical Pharmacology of Miami — Miami, Florida, United States
- Orlando Clinical Research Center — Orlando, Florida, United States
- GCP — St. Petersburg, Florida, United States
- Texas Liver Institute — San Antonio, Texas, United States
- CRU Hungary Unit Pest Country Flor Ferenc Hospital — Kistarcsa, Hungary
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.